(Post-pandemic Era)-Global The Antiparasitic Drugs Market Segment Research Report 2023

Report ID: 874129 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global The Antiparasitic Drugs Market Segment Research Report 2021
1. Research Scope
2. Market Overview
    2.1 Product Introduction, Application, Picture
    2.2 Global The Antiparasitic Drugs Market by Value
      2.2.1 Global The Antiparasitic Drugs Revenue by Type
      2.2.2 Global The Antiparasitic Drugs Market by Value (%)
    2.3 Global The Antiparasitic Drugs Market by Production
      2.3.1 Global The Antiparasitic Drugs Production by Type
      2.3.2 Global The Antiparasitic Drugs Market by Production (%)

3. The Major Driver of The Antiparasitic Drugs Industry
    3.1 Historical & Forecast Global The Antiparasitic Drugs Demand
    3.2 Largest Application for The Antiparasitic Drugs (2017-2027)
    3.3 The Major Downstream Company in China Market 2021

4. Global and Regional The Antiparasitic Drugs Market
    4.1 Regional Market Size in Terms of Production & Demand (2021)
    4.2 Regional Market Share in Terms of Revenue (2019-2027) 
    4.3 Concentration Ratio (CR5& CR10) of The Antiparasitic Drugs Market
    4.4 Mergers & Acquisitions, Expansion Plans

5. US The Antiparasitic Drugs Production, Demand (2017-2027)
    5.1 Current and Estimated Production Breakdown by Type
    5.2 Current and Estimated Demand Breakdown by Type
    5.3 Current and Estimated Demand Breakdown by Application
    5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe The Antiparasitic Drugs Production, Demand (2017-2027)
    6.1 Current and Estimated Production Breakdown by Type
    6.2 Current and Estimated Demand Breakdown by Type
    6.3 Current and Estimated Demand Breakdown by Application
    6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China The Antiparasitic Drugs Production, Demand (2017-2027)
    7.1 Current and Estimated Production Breakdown by Type
    7.2 Current and Estimated Demand Breakdown by Type
    7.3 Current and Estimated Demand Breakdown by Application
    7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan The Antiparasitic Drugs Production, Demand (2017-2027)
    8.1 Current and Estimated Production Breakdown by Type
    8.2 Current and Estimated Demand Breakdown by Type
    8.3 Current and Estimated Demand Breakdown by Application
    8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India The Antiparasitic Drugs Production, Demand (2017-2027)
    9.1 Current and Estimated Production Breakdown by Type
    9.2 Current and Estimated Demand Breakdown by Type
    9.3 Current and Estimated Demand Breakdown by Application
    9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea The Antiparasitic Drugs Production, Demand (2017-2027)
    10.1 Current and Estimated Production Breakdown by Type
    10.2 Current and Estimated Demand Breakdown by Type
    10.3 Current and Estimated Demand Breakdown by Application
    10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia The Antiparasitic Drugs Production, Demand (2017-2027)
    11.1 Current and Estimated Production Breakdown by Type
    11.2 Current and Estimated Demand Breakdown by Type
    11.3 Current and Estimated Demand Breakdown by Application
    11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global The Antiparasitic Drugs Average Price Trend
    12.1 Market Price for Each Type of The Antiparasitic Drugs in US (2017-2021)
    12.2 Market Price for Each Type of The Antiparasitic Drugs in Europe (2017-2021)
    12.3 Market Price for Each Type of The Antiparasitic Drugs in China (2017-2021)
    12.4 Market Price for Each Type of The Antiparasitic Drugs in Japan (2017-2021)
    12.5 Market Price for Each Type of The Antiparasitic Drugs in India (2017-2021)
    12.6 Market Price for Each Type of The Antiparasitic Drugs in Korea (2017-2021)
    12.7 Market Price for Each Type of The Antiparasitic Drugs in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
    13.1 The Antiparasitic Drugs Industrial Chain Analysis
    13.2 Downstream
    13.3 Impact of COVID-19
    13.4 Technology Trends of The Antiparasitic Drugs

14. The Antiparasitic Drugs Competitive Landscape
     14.1 Ipca Laboratories Ltd
        14.1.1 Ipca Laboratories Ltd Company Profiles
        14.1.2 Ipca Laboratories Ltd Product Introduction
        14.1.3 Ipca Laboratories Ltd The Antiparasitic Drugs Sales, Revenue (2017-2021)
        14.1.4 Strategic initiatives
     14.2 Novartis AG
        14.2.1 Novartis AG Company Profiles
        14.2.2 Novartis AG Product Introduction
        14.2.3 Novartis AG The Antiparasitic Drugs Sales, Revenue (2017-2021)
        14.2.4 Strategic initiatives
     14.3 Pfizer
        14.3.1 Pfizer Company Profiles
        14.3.2 Pfizer Product Introduction
        14.3.3 Pfizer The Antiparasitic Drugs Sales, Revenue (2017-2021)
        14.3.4 Strategic initiatives
     14.4 Zydus Cadila
        14.4.1 Zydus Cadila Company Profiles
        14.4.2 Zydus Cadila Product Introduction
        14.4.3 Zydus Cadila The Antiparasitic Drugs Sales, Revenue (2017-2021)
        14.4.4 Strategic initiatives
     14.5 Ranbaxy Laboratories
        14.5.1 Ranbaxy Laboratories Company Profiles
        14.5.2 Ranbaxy Laboratories Product Introduction
        14.5.3 Ranbaxy Laboratories The Antiparasitic Drugs Sales, Revenue (2017-2021)
        14.5.4 Strategic initiatives
     14.6 Merck
        14.6.1 Merck Company Profiles
        14.6.2 Merck Product Introduction
        14.6.3 Merck The Antiparasitic Drugs Sales, Revenue (2017-2021)
        14.6.4 Strategic initiatives
     14.7 Bayer AG
        14.7.1 Bayer AG Company Profiles
        14.7.2 Bayer AG Product Introduction
        14.7.3 Bayer AG The Antiparasitic Drugs Sales, Revenue (2017-2021)
        14.7.4 Strategic initiatives
     14.8 Cipla Ltd
        14.8.1 Cipla Ltd Company Profiles
        14.8.2 Cipla Ltd Product Introduction
        14.8.3 Cipla Ltd The Antiparasitic Drugs Sales, Revenue (2017-2021)
        14.8.4 Strategic initiatives
     14.9 GlaxoSmithKline Plc.
        14.9.1 GlaxoSmithKline Plc. Company Profiles
        14.9.2 GlaxoSmithKline Plc. Product Introduction
        14.9.3 GlaxoSmithKline Plc. The Antiparasitic Drugs Sales, Revenue (2017-2021)
        14.9.4 Strategic initiatives
     14.10 Alvizia Health Care
        14.10.1 Alvizia Health Care Company Profiles
        14.10.2 Alvizia Health Care Product Introduction
        14.10.3 Alvizia Health Care The Antiparasitic Drugs Sales, Revenue (2017-2021)
        14.10.4 Strategic initiatives
     14.11 Alkem Laboratories Limited
     14.12 Roche Inc
     14.13 AstraZeneca
     14.14 Arbor Pharmaceuticals Inc.
     14.15 Sanofi
15. Conclusion


List of Tables and Figures

    Figure 1. Total Demand by Application of The Antiparasitic Drugs Industry (Volume)
    Figure 2. The Antiparasitic Drugs Production & Demand by Regions in 2021
    Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
    Figure 4. The Top 10 and 5 Players Market Share by The Antiparasitic Drugs Revenue in 2021
    Figure 5. US The Antiparasitic Drugs Production, Demand (2017-2027)
    Figure 6. Production Breakdown by Type (%)
    Figure 7. Demand Breakdown by Type (%)
    Figure 8. Demand Breakdown by Application (%)
    Figure 9. Revenue Breakdown by Type (%)
    Figure 10. Revenue Breakdown by Application (%)
    Figure 11. Europe The Antiparasitic Drugs Production, Demand (2017-2027)
    Figure 12. Production Breakdown by Type (%)
    Figure 13. Demand Breakdown by Type (%)
    Figure 14. Demand Breakdown by Application (%)
    Figure 15. Revenue Breakdown by Type (%)
    Figure 16. Revenue Breakdown by Application (%)
    Figure 17. China The Antiparasitic Drugs Production, Demand (2017-2027)
    Figure 18. Production Breakdown by Type (%)
    Figure 19. Demand Breakdown by Type (%)
    Figure 20. Demand Breakdown by Application (%)
    Figure 21. Current and Estimated Revenue Breakdown by Type
    Figure 22. Revenue Breakdown by Type (%)
    Figure 23. Revenue Breakdown by Application (%)
    Figure 24. Japan The Antiparasitic Drugs Production, Demand (2017-2027)
    Figure 25. Production Breakdown by Type (%)
    Figure 26. Demand Breakdown by Type (%)
    Figure 27. Demand Breakdown by Application (%)
    Figure 28. Revenue Breakdown by Type (%)
    Figure 29. Revenue Breakdown by Application (%)
    Figure 30. India The Antiparasitic Drugs Production, Demand (2017-2027)
    Figure 31. Production Breakdown by Type (%)
    Figure 32. Demand Breakdown by Type (%)
    Figure 33. Demand Breakdown by Application (%)
    Figure 34. Revenue Breakdown by Type (%)
    Figure 35. Revenue Breakdown by Application (%)
    Figure 36. Korea The Antiparasitic Drugs Production, Demand (2017-2027)
    Figure 37. Production Breakdown by Type (%)
    Figure 38. Demand Breakdown by Type (%)
    Figure 39. Demand Breakdown by Application (%)
    Figure 40. Revenue Breakdown by Type (%)
    Figure 41. Revenue Breakdown by Application (%)
    Figure 42. Southeast Asia The Antiparasitic Drugs Production, Demand (2017-2027)
    Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
    Figure 44. Production Breakdown by Type (%)
    Figure 45. Demand Breakdown by Type (%)
    Figure 46. Revenue Breakdown by Type (%)
    Figure 47. Revenue Breakdown by Application (%)
    Figure 48. Industrial Chain
    Table 1. Top Manufacturers and Market Segmentation
    Table 2. Product Introduction, Application, Picture
    Table 3. The Antiparasitic Drugs Revenue, by Type (Million USD) (2017-2027)
    Table 4. The Antiparasitic Drugs Production, by Type (K Unit) (2017-2027)
    Table 5. The Antiparasitic Drugs Demand (K Unit) by Application (2017-2027)
    Table 6. The Antiparasitic Drugs Demand (Million USD) by Application (2017-2027)
    Table 7. The Major Downstream Company in China
    Table 8. Regional Market Share in Terms of Production & Demand (2021)
    Table 9. Regional Market Share in Terms of Revenue (2021&2027)
    Table 10. Ranking of Global Top The Antiparasitic Drugs Companies by Revenue, Concentration Ratio in 2021
    Table 11. Mergers & Acquisitions, Expansion Plans
    Table 12. US The Antiparasitic Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 16. Current and Estimated Revenue Breakdown by Type
    Table 17. Current and Estimated Revenue Breakdown by Application
    Table 18. Europe The Antiparasitic Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 22. Current and Estimated Revenue Breakdown by Type
    Table 23. Current and Estimated Revenue Breakdown by Application
    Table 24. China The Antiparasitic Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 25. Table Current and Estimated Production Breakdown by Type
    Table 26. Current and Estimated Demand Breakdown by Type
    Table 27. Current and Estimated Demand Breakdown by Application
    Table 28. Current and Estimated Revenue Breakdown by Application
    Table 29. Japan The Antiparasitic Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 33. Current and Estimated Revenue Breakdown by Type
    Table 34. Current and Estimated Revenue Breakdown by Application
    Table 35. India The Antiparasitic Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 39. Current and Estimated Revenue Breakdown by Type
    Table 40. Current and Estimated Revenue Breakdown by Application
    Table 41. Korea The Antiparasitic Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 45. Current and Estimated Revenue Breakdown by Type
    Table 46. Current and Estimated Revenue Breakdown by Application
    Table 47. Southeast Asia The Antiparasitic Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 50. Current and Estimated Revenue Breakdown by Type
    Table 51. Current and Estimated Revenue Breakdown by Application
    Table 52. Market Price (USD/Unit) for Each Type of The Antiparasitic Drugs in US (2017-2021)
    Table 53. Market Price (USD/Unit) for Each Type of The Antiparasitic Drugs in Europe (2017-2021)
    Table 54. Market Price (USD/Unit) for Each Type of The Antiparasitic Drugs in China (2017-2021)
    Table 55. Market Price (USD/Unit) for Each Type of The Antiparasitic Drugs in Japan (2017-2021)
    Table 56. Market Price (USD/Unit) for Each Type of The Antiparasitic Drugs in India (2017-2021)
    Table 57. Market Price (USD/Unit) for Each Type of The Antiparasitic Drugs in Korea (2017-2021)
    Table 58. Market Price (USD/Unit) for Each Type of The Antiparasitic Drugs in Southeast Asia (2017-2021)
    Table 59. Key Downstream Customer in Each Application Field
    Table 60. Ipca Laboratories Ltd Profiles
    Table 61. Ipca Laboratories Ltd The Antiparasitic Drugs Product Introduction
    Table 62. Ipca Laboratories Ltd The Antiparasitic Drugs Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 63. Ipca Laboratories Ltd Strategic initiatives
    Table 64. Novartis AG Profiles
    Table 65. Novartis AG The Antiparasitic Drugs Product Introduction
    Table 66. Novartis AG The Antiparasitic Drugs Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 67. Novartis AG Strategic initiatives
    Table 68. Pfizer Profiles
    Table 69. Pfizer The Antiparasitic Drugs Product Introduction
    Table 70. Pfizer The Antiparasitic Drugs Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 71. Pfizer Strategic initiatives
    Table 72. Zydus Cadila Profiles
    Table 73. Zydus Cadila The Antiparasitic Drugs Product Introduction
    Table 74. Zydus Cadila The Antiparasitic Drugs Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 75. Zydus Cadila Strategic initiatives
    Table 76. Ranbaxy Laboratories Profiles
    Table 77. Ranbaxy Laboratories The Antiparasitic Drugs Product Introduction
    Table 78. Ranbaxy Laboratories The Antiparasitic Drugs Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 79. Ranbaxy Laboratories Strategic initiatives
    Table 80. Merck Profiles
    Table 81. Merck The Antiparasitic Drugs Product Introduction
    Table 82. Merck The Antiparasitic Drugs Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 83. Merck Strategic initiatives
    Table 84. Bayer AG Profiles
    Table 85. Bayer AG The Antiparasitic Drugs Product Introduction
    Table 86. Bayer AG The Antiparasitic Drugs Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 87. Bayer AG Strategic initiatives
    Table 88. Cipla Ltd Profiles
    Table 89. Cipla Ltd The Antiparasitic Drugs Product Introduction
    Table 90. Cipla Ltd The Antiparasitic Drugs Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 91. Cipla Ltd Strategic initiatives
    Table 92. GlaxoSmithKline Plc. Profiles
    Table 93. GlaxoSmithKline Plc. The Antiparasitic Drugs Product Introduction
    Table 94. GlaxoSmithKline Plc. The Antiparasitic Drugs Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 95. GlaxoSmithKline Plc. Strategic initiatives
    Table 97. Alvizia Health Care Profiles
    Table 98. Alvizia Health Care The Antiparasitic Drugs Product Introduction
    Table 99. Alvizia Health Care The Antiparasitic Drugs Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 100. Alvizia Health Care Strategic initiatives
    Table 101. Alkem Laboratories Limited Profiles
    Table 102. Alkem Laboratories Limited The Antiparasitic Drugs Product Introduction
    Table 103. Alkem Laboratories Limited The Antiparasitic Drugs Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 104. Alkem Laboratories Limited Strategic initiatives
    Table 105. Roche Inc Profiles
    Table 106. Roche Inc The Antiparasitic Drugs Product Introduction
    Table 107. Roche Inc The Antiparasitic Drugs Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 108. Roche Inc Strategic initiatives
    Table 109. AstraZeneca Profiles
    Table 110. AstraZeneca The Antiparasitic Drugs Product Introduction
    Table 111. AstraZeneca The Antiparasitic Drugs Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 112. AstraZeneca Strategic initiatives
    Table 113. Arbor Pharmaceuticals Inc. Profiles
    Table 114. Arbor Pharmaceuticals Inc. The Antiparasitic Drugs Product Introduction
    Table 115. Arbor Pharmaceuticals Inc. The Antiparasitic Drugs Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 116. Arbor Pharmaceuticals Inc. Strategic initiatives
    Table 117. Sanofi Profiles
    Table 118. Sanofi The Antiparasitic Drugs Product Introduction
    Table 119. Sanofi The Antiparasitic Drugs Sales (Unit), Revenue (Million USD) (2017-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global The Antiparasitic Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global The Antiparasitic Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global The Antiparasitic Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports